Dr. Kasper on Imatinib in Recist Progressive Desmoid Tumors
0 Views
administrator
07/04/23
Bernd Kasper, MD, PhD, professor, Universitätsmedizin Mannheim, Mannheim, discusses results of a phase II study exploring the efficacy of imatinib (Gleevac) in patients with racist progressive desmoid tumors.
-
Category
Show more
Facebook Comments
No comments found